Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Current Taxes (2020 - 2021)

Historic Current Taxes for Aytu Biopharma (AYTU) over the last 2 years, with Q1 2021 value amounting to $182000.0.

Aytu Biopharma's Current Taxes changed N/A to $182000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $182000.0, marking a year-over-year change of. This contributed to the annual value of $175000.0 for FY2020, which is N/A changed from last year.
As of Q1 2021, Aytu Biopharma's Current Taxes stood at $182000.0.
Aytu Biopharma's Current Taxes' 5-year high stood at $182000.0 during Q1 2021, with a 5-year trough of $175000.0 in Q2 2020.